Extend your brand profile by curating daily news.

Octane Announces Cardiovascular Tech Forum 2025 to Drive Medical Innovation

By Advos

TL;DR

Octane's Cardiovascular Tech Forum 2025 offers entrepreneurs and investors exclusive access to cutting-edge medical innovations and networking with industry leaders for strategic advantage.

The forum on September 11-12, 2025 at VEA Newport Beach features innovation panels, workshops, investor presentations, and networking sessions focused on cardiology technology.

This event accelerates medical solutions that will improve patient outcomes and strengthen healthcare systems for better community well-being.

Pioneering cardiologist Dr. John B. Simpson headlines the forum showcasing breakthroughs in interventional cardiology and medical device innovation.

Found this article helpful?

Share it with your network and spread the knowledge!

Octane Announces Cardiovascular Tech Forum 2025 to Drive Medical Innovation

Octane, a leading organization fueling technology growth in Southern California, announced the Octane Cardiovascular Tech Forum 2025 will take place September 11-12, 2025, at VEA Newport Beach, A Marriott Resort & Spa. The event serves as a cornerstone of Octane's Innovation Event Series and will unite entrepreneurs, investors, physicians, and industry leaders to highlight the latest advances in interventional cardiology, digital health, imaging, and medical devices.

The forum's significance lies in its potential to accelerate solutions that could redefine patient outcomes and strengthen the healthcare ecosystem. Program highlights include innovation panels, a physician and entrepreneur workshop, investor-focused presentations, and networking sessions designed to foster collaboration and drive technological advancement in cardiovascular care.

Dr. John B. Simpson, a pioneering interventional cardiologist and inventor of the over-the-wire balloon angioplasty catheter, will headline the event as keynote speaker. The forum's committee features leaders from prominent organizations including Edwards Lifesciences, Cathworks, Knobbe Martens, UC Irvine, Hoag Hospital, and Nidus Biomedical, who will guide the agenda and ensure the event addresses critical industry challenges.

According to CEO Bill Carpou, the forum represents a strategic initiative to connect people, resources, and capital within the Southern California technology ecosystem. Octane's mission focuses on driving innovation and growth by facilitating the exchange of ideas, knowledge, and resources that fuel the development of tech and medtech industries. More information about Octane's initiatives can be found at https://www.octaneoc.org.

The Cardiovascular Tech Forum 2025 holds importance for the medical technology sector as it provides a platform for showcasing cutting-edge innovations that could transform cardiovascular treatment methodologies. The event's timing coincides with increasing global demand for advanced medical technologies and digital health solutions, particularly in cardiology where technological advancements continue to improve patient care and outcomes.

For additional details about the forum and Octane's broader impact on the technology community, interested parties can access the full announcement through the organization's communications channels. The event is expected to attract significant attention from across the medical technology landscape, reflecting the growing importance of collaborative innovation in addressing complex healthcare challenges.

blockchain registration record for this content
Advos

Advos

@advos